Literature DB >> 1136801

Proceedings: "First-pass" effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man.

C Bahr, G Alván, M Lind, B Mellström, V Sjöqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 1136801

Source DB:  PubMed          Journal:  Acta Pharm Suec        ISSN： 0001-6675


× No keyword cloud information.
  8 in total

1.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

2.  Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.

Authors:  G Alván; M Lind; B Mellström; C von Bahr
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

3.  Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect.

Authors:  J Meier; E Nüesch
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

4.  Long term effect of timolol and hydrochlorothiazide, or hydrochlorothiazide and amiloride, in essential hypertension.

Authors:  H Castenfors
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

Review 5.  Individual differences in the disposition of drugs metabolised in the body.

Authors:  G Alvan
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

6.  Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.

Authors:  P C O'Connor; J M Arnold; A N Brown; R J Francis; M B Finch; D B Galloway; D W Harron; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  Pharmacokinetics of tolamolol in the treatment of hypertension.

Authors:  P A Routledge; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.